BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27692535)

  • 1. Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer.
    Larcher A; Sun M; Dell'Oglio P; Trudeau V; Boehm K; Schiffmann J; Tian Z; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
    Eur J Surg Oncol; 2017 Apr; 43(4):815-822. PubMed ID: 27692535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma.
    Larcher A; Meskawi M; Valdivieso R; Boehm K; Trudeau V; Tian Z; Fossati N; Dell'Oglio P; Lughezzani G; Buffi N; Sun M; Karakiewicz P
    World J Urol; 2016 Mar; 34(3):383-9. PubMed ID: 26047653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates.
    Larcher A; Fossati N; Tian Z; Boehm K; Meskawi M; Valdivieso R; Trudeau V; Dell'Oglio P; Buffi N; Montorsi F; Guazzoni G; Sun M; Karakiewicz PI
    Eur Urol; 2016 Apr; 69(4):676-682. PubMed ID: 26206408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
    Palumbo C; Mistretta FA; Knipper S; Mazzone E; Pecoraro A; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lavallee LT; Karakiewicz PI
    Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
    Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
    World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series.
    Sun M; Abdollah F; Shariat SF; Schmitges J; Trinh QD; Tian Z; Jeldres C; Abdo A; Bianchi M; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Surg Oncol; 2012 Jan; 38(1):80-7. PubMed ID: 21996370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost comparison of nephron-sparing treatments for cT1a renal masses.
    Castle SM; Gorbatiy V; Avallone MA; Eldefrawy A; Caulton DE; Leveillee RJ
    Urol Oncol; 2013 Oct; 31(7):1327-32. PubMed ID: 22361086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study.
    Trudeau V; Larcher A; Boehm K; Dell'Oglio P; Sun M; Tian Z; Briganti A; Shariat SF; Jeldres C; Karakiewicz PI
    Urology; 2016 Mar; 89():63-7. PubMed ID: 26514977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
    Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
    Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project).
    Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Ficarra V; Fiori C; Furlan M; Giancane S; Longo N; Mirone V; Morgia G; Porpiglia F; Rovereto B; Schiavina R; Serni S; Simeone C; Volpe A; Carini M; Minervini A
    Eur J Surg Oncol; 2017 Apr; 43(4):823-830. PubMed ID: 27876194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Tumor Enucleation and Laparoscopic Partial Nephrectomy for Clinical T1a Renal Tumor: A Randomized Clinical Trial.
    Huang J; Zhang J; Wang Y; Kong W; Xue W; Liu D; Chen Y; Huang Y
    J Urol; 2016 Jun; 195(6):1677-83. PubMed ID: 26905020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Perioperative Morbidity and Mortality Rates of Minimally Invasive
    Khalil MI; Ubeda J; Soehner T; Bhandari NR; Payakachat N; Davis R; Raheem OA; Kamel MH
    J Endourol; 2019 Nov; 33(11):920-927. PubMed ID: 31333072
    [No Abstract]   [Full Text] [Related]  

  • 15. [Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure].
    Arnoux V; Descotes JL; Sengel C; Terrier N; Rambeaud JJ; Long JA
    Prog Urol; 2013 Feb; 23(2):99-104. PubMed ID: 23352302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A propensity-matched comparison of perioperative complications and of chronic kidney disease between robot-assisted laparoscopic partial nephrectomy and radiofrequency ablative therapy.
    Kim SH; Lee ES; Kim HH; Kwak C; Ku JH; Lee SE; Hong SK; Jeong CW; Kim SH; Cho JY; Hwang SI; Lee HJ; Byun SS
    Asian J Surg; 2015 Jul; 38(3):126-33. PubMed ID: 25458737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
    Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
    Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected Outcomes.
    Uhlig J; Kokabi N; Xing M; Kim HS
    Radiology; 2018 Sep; 288(3):889-897. PubMed ID: 29969077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
    Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.